STOCK TITAN

The Ensign Group (ENSG) Form 4 Filings

ENSG NASDAQ

Every Form 4 that The Ensign Group, Inc. (ENSG) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow ENSG and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ENSG filings page.

Rhea-AI Summary

The Ensign Group director Ann Scott Blouin reported selling 375 shares of common stock on February 9, 2026. The shares were sold at a price of $198 per share under a pre-arranged Rule 10b5-1 trading plan adopted on November 7, 2025.

After this transaction, Blouin beneficially owned 22,852 Ensign Group shares, held in direct ownership. The filing reflects a planned, programmatic sale by a board member rather than a discretionary, one-time trade.

Rhea-AI Summary

The Ensign Group director Mark Vincent Parkinson reported a small pre-planned stock sale. On February 9, 2026, he sold 100 shares of Ensign Group common stock at $198 per share under a Rule 10b5-1 trading plan adopted on November 6, 2025. After this transaction, he directly beneficially owned 2,900 shares of Ensign Group common stock.

Rhea-AI Summary

Ensign Group, Inc. CFO and director Suzanne D. Snapper reported stock option exercises and related common stock sales. On February 5–6, 2026, she exercised employee stock options for multiple blocks of 4,129 common shares at exercise prices of $15.80 and $15.93 per share.

On February 5–6, 2026, she sold several blocks of Ensign common stock at weighted average prices ranging from about $185.22 to $197.21 per share under a Rule 10b5-1 trading plan adopted on September 12, 2025. After these transactions, she directly owned 272,889 common shares and indirectly held 56,340 shares through the Eric and Suzanne Snapper Family Trust.

Rhea-AI Summary

Ensign Group director Barry M. Smith reported a planned sale of company stock. On February 2, 2026, he sold 700 shares of common stock at $171.54 per share in an open-market transaction. The trade was made under a Rule 10b5-1 trading plan adopted on July 29, 2025, indicating it was pre-arranged. After this sale, he beneficially owns 23,552 shares of Ensign Group common stock directly.

Rhea-AI Summary

Ensign Group director John O. Agwunobi reported small, pre-planned stock sales. On January 20, 2026, he sold 246 shares of Ensign Group common stock at an average price of $179.82 per share. On January 21, 2026, he sold an additional 146 shares at an average price of $178.31 per share, for a total of 392 shares sold.

After these transactions, he beneficially owned 9,087.149 Ensign Group shares in direct form. The filing states these sales were executed under a Rule 10b5-1 trading plan adopted on July 31, 2025, which is a pre-arranged program allowing insiders to sell shares according to preset instructions.

Rhea-AI Summary

Ensign Group, Inc. director and CFO Suzanne Snapper filed an amended Form 4 to correct how a prior stock gift was reported. A November 7, 2025 gift of 2,675 shares of common stock had previously been shown as coming from her direct holdings. This amendment clarifies that the gifted shares were held indirectly through a trust rather than directly.

Following the corrected reporting, Snapper is shown as owning 269,204 shares of Ensign Group common stock directly and 56,340 shares indirectly, held by the Eric and Suzanne Snapper Family Trust, of which she and her spouse are trustees. The transaction was a gift reported at a price of $0 per share and does not reflect a market sale.

Rhea-AI Summary

Ensign Group, Inc. director Barry M. Smith reported an equity award of 600 shares of common stock on January 15, 2026, at a grant price of $0 per share. After this award, he beneficially owns 24,252 shares of Ensign Group common stock directly. The 600 granted shares are subject to vesting in three equal annual installments beginning on January 15, 2027, meaning they become fully his over a three-year period if vesting conditions are met.

Rhea-AI Summary

The Ensign Group director reports a new stock grant. Director Daren Shaw received an award of 600 shares of Ensign Group common stock on January 15, 2026 at a price of $0 per share. Following this award, he beneficially owns 24,726 common shares directly.

The grant is subject to a multi-year vesting schedule. The 600 shares vest in three equal annual installments beginning January 15, 2027, meaning one-third of the award becomes fully owned each year over three years.

Rhea-AI Summary

The Ensign Group director reports a new stock award. Director Ann Scott Blouin acquired 600 shares of Ensign Group common stock on January 15, 2026 in a transaction reported at a price of $0 per share, indicating a share grant rather than a market purchase. After this award, she beneficially owns 23,227 Ensign Group shares in direct ownership.

The filing notes that these 600 shares vest in three equal annual installments beginning January 15, 2027, so the director will earn the shares over time rather than receiving them all at once.

Rhea-AI Summary

The Ensign Group director Abbott Swati Bargotra reported receiving 600 shares of common stock of The Ensign Group, Inc. on January 15, 2026 in a Form 4 filing. The shares were acquired at a stated price of $0 per share, indicating they were granted as equity compensation rather than purchased on the market. Following this award, Bargotra beneficially owns 19,632 shares of Ensign common stock in total. According to the footnote, these 600 shares vest in three equal annual installments beginning on January 15, 2027, meaning the director earns the shares over time, subject to the vesting schedule.

Rhea-AI Summary

The Ensign Group director receives stock grant

Director John O. Agwunobi reported an award of 600 shares of Ensign Group common stock on January 15, 2026, at a stated price of $0 per share, indicating a stock-based compensation grant rather than an open-market purchase. After this grant, he beneficially owns 9,479.149 shares directly.

The footnote explains that these 600 shares are subject to a vesting schedule, vesting in three equal annual installments beginning January 15, 2027, which spreads the compensation over time and ties it to continued service.

Rhea-AI Summary

The Ensign Group director reports new stock award. Director Mark Vincent Parkinson reported receiving 600 shares of The Ensign Group, Inc. common stock on January 15, 2026, recorded at a price of $0 per share, indicating an equity grant rather than a market purchase. After this award, he beneficially owns 3,000 shares of common stock in total.

The 600-share award is structured to vest over time, with the shares vesting in three equal annual installments beginning on January 15, 2027. This staged vesting schedule ties the director’s equity compensation to continued service with the company.

Rhea-AI Summary

The Ensign Group, Inc. reported an insider stock transaction by its VP and Chief Legal Officer. On December 12, 2025, the officer exercised 2,500 employee stock options at an exercise price of $44.84 per share, acquiring the same number of common shares.

On the same date, the officer sold 1,000, 5,846 and 1,554 shares of common stock at weighted average sale prices of $174.1075, $175.516 and $176.207, respectively, leaving 32,779 common shares owned directly after the transactions and no remaining derivative securities. The activity was effected under a Rule 10b5-1 trading plan adopted on September 2, 2025, using options originally granted on May 28, 2020 that vest over five equal annual installments.

Rhea-AI Summary

The Ensign Group, Inc. (ENSG) officer, the President and COO, reported an option exercise and share sale. On 11/20/2025, he exercised 3,690 employee stock options at an exercise price of $15.93 per share, receiving the same number of common shares. On the same date, he sold 3,690 common shares at a price of $180 per share. After these transactions, he beneficially owned 51,165 shares of Ensign common stock in direct ownership form.

The filing states that the transaction was carried out under a Rule 10b5-1 trading plan adopted on August 14, 2025. The options exercised were originally granted on August 31, 2016 and vested in five equal annual installments.

Rhea-AI Summary

Ensign Group, Inc. (ENSG) President and COO filed a Form 4 reporting multiple stock transactions in November 2025. On 11/17/2025, the officer made a gift of 4,229 shares of common stock and exercised stock options for 5,899 shares at $16.60 per share, then sold 5,899 shares at $177.30 per share. On 11/18/2025, the officer exercised options for 2,209 shares at $15.93 per share and sold 2,209 shares at $180.00 per share. After these transactions, the officer directly owned 51,165 shares of Ensign Group common stock and held 3,690 employee stock options. The filing notes that the transactions were carried out under a Rule 10b5-1 trading plan adopted on August 14, 2025.

Rhea-AI Summary

Ensign Group, Inc. director reports small stock sale under 10b5-1 plan. A company director filed a Form 4 disclosing the sale of 1,000 shares of Ensign Group, Inc. common stock at a price of $178.57 per share on 11/18/2025. The transaction was coded as a sale and executed pursuant to a pre-arranged Rule 10b5-1 trading plan adopted on May 7, 2025. After this trade, the director beneficially owns 24,126 shares of Ensign Group, Inc., all held directly.

Rhea-AI Summary

Ensign Group (ENSG) reported insider transactions by CEO and director Barry R. Port. On 11/11/2025, a trust for the reporting person disposed of 4,820 shares as a gift. On 11/12/2025, he exercised options for 28,315 shares (at $15.80 and $45.34) and sold the same 28,315 shares in multiple trades under a Rule 10b5‑1 plan adopted August 12, 2025. Sale prices ranged from $179.4445 to $182.9538 based on weighted averages.

Following the sales, direct holdings were 56,481 shares. Indirect holdings by trust were 150,480 shares following the gift.

Rhea-AI Summary

Ensign Group (ENSG) reported an insider transaction by its CFO and Director, Suzanne Snapper. On 11/07/2025, a Form 4 entry shows a code G transaction involving 2,675 shares of common stock at a stated price of $0. Following this transaction, the reporting person beneficially owned 266,529 shares directly.

In addition, the filing lists 59,015 shares held indirectly by the Eric and Suzanne Snapper Family Trust, for which Suzanne and Eric Snapper serve as trustees. The form was signed by Chad A. Keetch as power of attorney.

Rhea-AI Summary

Ensign Group (ENSG) reported a director’s Form 4 showing new equity awards and a small tax-related sale. On 11/05/2025, the director acquired 1,600 shares of common stock at $0, and received an option to buy 4,000 shares at an exercise price of $189.93.

The option vests in five equal annual installments beginning November 5, 2026 and expires on November 5, 2035. On 11/07/2025, 73 shares were sold at $182.08 pursuant to a Rule 10b5-1 plan to cover taxes related to a prior restricted stock award. Following these transactions, the director beneficially owned 14,490 shares, held directly.

Rhea-AI Summary

Ensign Group (ENSG) reported an insider transaction by a director. On 11/06/2025, the director sold 246 shares of common stock at $188.87 per share, reported with transaction code S. Following the sale, the director beneficially owns 8,879.149 shares, held directly. The filing notes the trade was effected under a Rule 10b5-1 trading plan adopted on July 31, 2025.

Rhea-AI Summary

Ensign Group (ENSG) reported an insider transaction by its Chief Executive Officer and Director. On 11/06/2025, the reporting person used 549 shares of common stock to cover tax withholding from a previously granted restricted stock award, coded F, at a price of $182.91 per share.

Following the transaction, beneficial ownership stands at 56,481 shares held directly and 155,300 shares held indirectly by a trust. The restricted stock award was granted on November 6, 2024 and vests in five equal annual installments beginning November 6, 2025.

Rhea-AI Summary

Ensign Group (ENSG) reported an insider transaction by its CFO and director. On 11/06/2025, 488 shares of common stock were withheld (Transaction Code F) at $182.91 per share to cover taxes upon vesting of a Restricted Stock Award granted on 11/06/2024 that vests in five equal annual installments beginning 11/06/2025.

Following the transaction, the reporting person beneficially owned 269,204 shares directly and 59,015 shares indirectly by trust.

Rhea-AI Summary

Ensign Group (ENSG) reported an insider Form 4 for Chad A. Keetch, the company’s CIO, EVP and Secretary. On 11/06/2025, a transaction coded F recorded the withholding of 386 shares of common stock at $182.91 per share to cover taxes tied to equity vesting.

The filing notes these shares relate to a Restricted Stock Award granted on 11/06/2024 that vests in five equal annual installments beginning 11/06/2025. Following the transaction, Keetch beneficially owns 94,414 shares, held directly. This is an administrative tax-withholding event rather than an open‑market sale.

Rhea-AI Summary

Ensign Group (ENSG) Form 4: The President and COO reported a tax withholding transaction on 11/06/2025. A total of 351 shares of common stock were withheld under code F at $182.91 per share in connection with a restricted stock award vesting.

Following this transaction, the executive beneficially owns 55,394 shares, held directly. The filing notes the underlying award was granted on November 6, 2024 and vests in five equal annual installments beginning November 6, 2025.

Rhea-AI Summary

Ensign Group (ENSG) insider activity: A company director reported a sale of common stock. On 11/03/2025, the director sold 700 shares at $180.64 per share pursuant to a Rule 10b5-1 trading plan adopted on July 31, 2024. Following the transaction, the director beneficially owns 25,052 shares, held directly. The filing was made by one reporting person.